The global Urinary Tract Infection Therapeutic Market is estimated to be valued at US$ 9193.23 Mn in 2023 and is expected to exhibit a CAGR of 3.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Urinary tract infections are caused by the presence and growth of bacteria in the urinary tract. Antibiotics are commonly prescribed medications used to treat urinary tract infections by killing or stopping the growth of bacteria causing the infection. They provide rapid relief from symptoms such as pain or burning sensation during urination.
Market key trends:
One of the key trends in the urinary tract infection therapeutic market is the rise in research and development of novel antibiotics. Growing antimicrobial resistance requires the development of new molecules that can overcome resistance. Several pharmaceutical companies are engaged in R&D of novel antibiotics using new mechanisms of action to fight multidrug-resistant bacterial strains causing urinary tract infections. Additionally, the market has witnessed a shift towards personalized therapy. Diagnostics play a key role in determining the causative organism and its antibiotic susceptibility to enable targeted treatment, minimizing overuse of broad-spectrum antibiotics. This enhances patient outcomes and helps curb antimicrobial resistance.
Segment Analysis
The Global Urinary Tract Infection Therapeutic Market Size is segmented by infection type, drug class, and distribution channel. By infection type, the uncomplicated infection segment held the largest market share in 2023 as these infections are more common and do not involve the kidneys or upper urinary tract. By drug class, the fluoroquinolones segment dominated as they are widely used first line treatment drugs for uncomplicated urinary tract infections owing to their effectiveness.
Key Takeaways
The global urinary tract infection therapeutic market is expected to witness high growth, exhibiting a CAGR of 3.0% over the forecast period, due to increasing prevalence of urinary tract infections worldwide.
By 2030, the market is estimated to reach US$ 11,868.75 Mn. North America currently dominates the market and is expected to continue its dominance over the forecast period owing to increasing healthcare expenditure and growing elderly population in the region which is more prone to UTIs.
North America is expected to remain the largest as well as the fastest growing regional market over the forecast period due to growing incidence of urinary tract infections and presence of highly developed healthcare systems. The Asia Pacific market is expected to exhibit high growth due to rising geriatric population, improving healthcare infrastructure and increased healthcare spending in the region.
Key players operating in the urinary tract infection therapeutic market are Pfizer, Novartis AG, Cipla Inc., Bayer AG, AstraZeneca, Shionogi & Co. Ltd., and GlaxoSmithKline PLC, among others. Pfizer dominates the market with its broads portfolio of UTI drugs like CIPRO.
Read Our More Blogs : https://www.rapidwebwire.com/urinary-tract-infection-therapeutics-market-size-share-analysis-2023-2030/
The Urinary Tract Infection Treatment Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the urinary tract infection treatment market include AstraZeneca, Bayer AG, Cipla, Inc., GlaxoSmithKline PLC, MerlionPharma, Novartis AG and Pfizer.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Urinary Tract Infection Treatment Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/urinary-tract-infection-treatment-market/download-sampleMarket DynamicsThe increasing prevalence of diabetes and kidney stones is primarily driving the market growth.
However, lack of awareness in developing and underdeveloped economies is likely to hamper the market growth.
Whereas, the increasing recurrence rate for UTIs is expected to augment the demand for treatment over the forecast period.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
